The company continues its regulatory success in Asia’s early life nutrition market with approval of four new HMOs in Malaysia and Thailand alongside commercial authorization of its 3’-SL ingredient in China
This collaboration underscores Barentz’s role as a leading global specialty ingredients provider, expanding its portfolio into advanced animal nutrition solutions.
As a result, its use has largely been confined to premium infant formula and specialist medical nutrition.
Brenntag opens a purpose-built Nutrition Innovation and Application Centre in Mumbai to support food and beverage manufacturers across Asia Pacific.
dsm-firmenich will retain a 20% equity stake in the divested ANH Companies, in partnership with CVC.